Healthcare Global Enterprises Ltd

Q3 FY26Healthcare Services

Healthcare Global Enterprises Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹726

Market cap₹10.7K Cr

P/E221.4

Updated23 Aug 2026

Read4 min read

The short version

Expected sales growth is 15%+ annually, with aspirations to exceed this target. The company expects sales growth of 15%+, with about 10% coming from volume growth and 5% from ARPP growth (Page 16).

From Healthcare Global Enterprises Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Expected sales growth is 15%+ annually, with aspirations to exceed this target.
Growth drivers: approximately 10% from volume growth and about 5% from Average Revenue per Patient (ARPP) growth.
Existing facilities currently operate at ~60% revenue potential, indicating significant headroom for growth.
Incremental bed additions of around 1,000 beds planned over the next 3-4 years, boosting capacity from ~2,200 to ~3,200+ beds.
Volume growth of about 8%-10% expected in key markets like Vizag and Bangalore.
New facilities launching include North Bangalore (120+ beds) by end of FY '27 and Whitefield in Bangalore.

2 more points management made on revenue & sales performance

Profitability & Margins

The company expects sales growth of 15%+, with about 10% coming from volume growth and 5% from ARPP growth (Page 16).
EBITDA margin is projected to rise, with mature centers already delivering 25%-26% EBITDA margins and close to 30% ROCE; broad company margin aspirations are 23%-24% in 3-4 years (Pages 13 and 8).
Adjusted EBITDA for Q3FY26 was INR 111 crore, up 20% YoY; margins expanded to 17.5% from 16.5% (Page 3).
Revenue growth in 9M FY26 stood at 16% YoY with adjusted EBITDA growth of 20%, indicating strong earnings momentum (Page 6).
ROCE is currently 13.3% (pre-tax) with expectations to improve to about 20% over the next 4-5 years due to operational leverage and capex optimization (Pages 13 and 6).

2 more points management made on profitability & margins

See what Healthcare Global Enterprises Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Expected capex for current year (FY '26) is about INR 275 crore - INR 280 crore.
Capex for next year (FY '27) is expected to be 10% - 12% higher than FY '26.
Planned addition of about 1,000 beds over the next 3-4 years, increasing from around 2,500-2,600 beds to about 3,500 beds.
Two upcoming greenfield projects in Bangalore (North Bangalore with 120+ beds and Whitefield), expected operational by end of FY '27.
Addition of about 20 beds by reconfiguring specs of the existing Centre of Excellence in Bangalore.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company announced a Rights Issue, which is an equity infusion intended to strengthen the balance sheet and capital structure.
The Rights Issue is part of a calibrated capital allocation framework to support growth.
As of the discussion, no specific details on the use of funds from the Rights Issue have been disclosed; specifics will be shared after the Board meeting.

2 more points management made on fundraising & capital structure

See what Healthcare Global Enterprises Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript and document do not mention any details about the current or expected order book or pending orders for Healthcare Global Enterprises Limited. The focus of the discussion is primarily on financial performance, growth plans, bed capacity expansion, sales growth drivers (ARPP and volume), capex guidance, and operational metrics. There is no reference to order books or pending orders in the Q3 & 9M FY26 earnings call transcript or associated documents.

Healthcare Global Enterprises Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹652 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Health.Global's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Healthcare Global Enterprises Ltd Q3 FY26 results?

Expected sales growth is 15%+ annually, with aspirations to exceed this target. The company expects sales growth of 15%+, with about 10% coming from volume growth and 5% from ARPP growth (Page 16).

What is Healthcare Global Enterprises Ltd share price analysis?

Healthcare Global Enterprises Ltd currently shows a neutral. The stock trades at a P/E of 221.3 with a market cap of ₹10,665 Cr. Investors should review the full earnings analysis for detailed insights.

Is Healthcare Global Enterprises Ltd planning capital expenditure?

Expected capex for current year (FY '26) is about INR 275 crore - INR 280 crore.

Keep Healthcare Global Enterprises Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.